CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
aspirindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01867281
NCT01867281Phase 4Completed
CompareCT.gov

The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases

Tehran University of Medical Sciences·interventional·Posted Jun 3, 2013·Updated Jul 1, 2014

In Brief

A Phase 4 clinical trial evaluating aspirin for Asthma, Aspirin-Induced. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effect of aspirin desensitization on symptoms and immunologic profile of patients with aspirin-exacerbated respiratory diseases (AERD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Aspirin-Induced
CountriesIran
CollaboratorsRassoul Akram Hospital

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 3, 2013
Enrollment StartJun 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.1 years ago

Interventions

aspirindrug